Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TDAC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -240.25 Med: 0 Max: 0
Current: -238.93
TDAC's EV-to-EBITDA is ranked worse than 100% of 150
companies
in the Diversified Financial Services industry
Industry Median: 4.425
vs TDAC: -238.93
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Translational Development Acquisition (NAS:TDAC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Translational Development Acquisition's PE Ratio (TTM) for today is calculated as:
Translational Development Acquisition's share price for today is $10.84.
Translational Development Acquisition's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.280.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Translational Development Acquisition EV-to-EBITDA Chart
Translational Development Acquisition Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
EV-to-EBITDA
0.00
0.00
0.00
-243.37
Translational Development Acquisition Quarterly Data
For the Shell Companies subindustry, Translational Development Acquisition's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Translational Development Acquisition EV-to-EBITDA vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Translational Development Acquisition's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Translational Development Acquisition's EV-to-EBITDA falls into.
Translational Development Acquisition's current Enterprise Value is $209.78 Mil.
Translational Development Acquisition's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.88 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Translational Development Acquisition (TDAC) has a EV-to-EBITDA of -238.93 as of Jul. 28, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Translational Development Acquisition. According to the industry distribution chart, Translational Development Acquisition ranks #999999 out of 150 companies in the Diversified Financial Services industry.
Is Translational Development Acquisition's EV-to-EBITDA too high?
Translational Development Acquisition's current EV-to-EBITDA is -238.93. Based on the distribution chart, Translational Development Acquisition ranks #999999 out of 150 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers. Overall, Translational Development Acquisition has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Translational Development Acquisition's EV-to-EBITDA compare to WLII and AESP?
According to the Diversified Financial Services industry distribution chart, Translational Development Acquisition ranks #999999 out of 150 companies for EV-to-EBITDA. This places Translational Development Acquisition in the lower half of its industry. The industry median EV-to-EBITDA is 4.43. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Diversified Financial Services company?
The median EV-to-EBITDA among Diversified Financial Services companies is 4.43, based on 150 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Translational Development Acquisition. For the Diversified Financial Services industry, the median EV-to-EBITDA is 4.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Translational Development Acquisition's current EV-to-EBITDA is -238.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Translational Development Acquisition stock overvalued right now?
Translational Development Acquisition (TDAC) has a current EV-to-EBITDA of -238.93. The current EV-to-EBITDA is -238.93. Translational Development Acquisition's overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Translational Development Acquisition (TDAC), the current EV-to-EBITDA is -238.93 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Translational Development Acquisition Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TDAC has been successfully added to your 
